MTOR and Alzheimer disease: The current study investigates the possible impact of dapagliflozin on the cholinergic system, glucose metabolism, AMPK/mTOR and OS in AD, clarifying the underlying mechanism of the alleged neuroprotective action of dapagliflozin.